Search Results 101-110 of 22970 for Phase

  1. Delayed sleep phase - Doctors and departments - Mayo Clinic

    Publications. See a list of publications about delayed sleep phase by Mayo Clinic doctors on PubMed, a service of the National Library of Medicine.

  2. 221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease - Mayo Clinic

    221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease · Overview · Participation eligibility · Participating Mayo Clinic locations · More ...

  3. A Phase 1B Dose-escalation Study of TRC105 in Combination With Pazopanib in Patients With Advanced Soft Tissue Sarcoma - Mayo Clinic

    The purpose of the phase 2 portion is to estimate the PFS of patients with advanced soft tissue sarcoma by RECIST 1.1. Participation eligibility. Participant ...

  4. Phase 1 Crohn's Pediatric Sub-study of MSC AFP - Mayo Clinic

    The investigators propose to study the safety of autologous mesenchymal stromal cell transfer using a biomatrix (the Gore Bio-A Fistula Plug) in a Phase I study ...

  5. South Beach Diet - Mayo Clinic

    The South Beach Diet has three phases: Phase 1. This two-week phase aims to jump-start your weight loss. You cut out almost all carbs from your diet. That ...

  6. Phase 1/2 Dose Escalation Study in Patients With Relapsed or Refractory Waldenstrom's Macroglobulinemia - Mayo Clinic

    Recent reports have identified a specific oncogenic mutation L265P of the MYD88 gene in approximately 90% of the patients with Waldenström's macroglobulinemia.

  7. Safety Study of CC-93538 in Adult and Adolescent Participants With Eosinophilic Esophagitis - Mayo Clinic

    Study phase. 3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  8. Re-treatment From a Phase I Study of MSC-AFP in Patients With Perianal Fistulas - Mayo Clinic

    This study is an extension to re-treat partial and non-responders from the previously approved Phase 1 MCS-AFP protocols IRB #12-009716 (Crohn's Disease ...

  9. A Phase IV Post Approval Clinical Study of ExAblate Treatment of Metastatic Bone Tumors for the Palliation of Pain

    About this study. The study hypotheses is that the proportion of patients experiencing clinically significant pain relief will be at least 30% greater than ...

  10. Phase II Trial of Irinotecan, Cetuximab, and Bevacizumab Compared With Irinotecan, Cetuximab, and Placebo in KRAS-Wildtype, Irinotecan-Refractory, Metastatic Colorectal Cancer - Mayo Clinic

    Phase II Trial of Irinotecan, Cetuximab, and Bevacizumab Compared With Irinotecan, Cetuximab, and Placebo in KRAS-Wildtype, Irinotecan-Refractory, Metastatic ...